Evidence map›Paper›PMID 24608164›Full record

ReviewCurrent opinion in neurobiology2014

Myelin-associated inhibitors in axonal growth after CNS injury.

Cédric G Geoffroy, Binhai Zheng

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in neurobiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Journal of Zhejiang University. Science. B · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Glial Control of Cortical Neuronal Circuit Maturation and Plasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cédric G GeoffroyDepartment of Neurosciences, University of California at San Diego, La Jolla, CA, USA.
Binhai ZhengDepartment of Neurosciences, University of California at San Diego, La Jolla, CA, USA. Electronic address: binhai@ucsd.edu.
University of California, San Diego · US

Funding

Genetic analysis of myelin inhibitors and PTEN in injury-inducedCNS axon growthR01NS054734 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHENG, BINHAI · 2007 to 2015
$3.2M
NINDS NIH HHS R01 NS054734NINDS NIH HHS R01NS054734
6 · The paper itself

Abstract

There are multiple barriers to axonal growth after CNS injury. Myelin-associated inhibitors represent one group of barriers extrinsic to the injured neurons. Nogo, MAG and OMgp are three prototypical myelin inhibitors that signal through multiple neuronal receptors to exert growth inhibition. Targeting myelin inhibition alone modulates the compensatory sprouting of uninjured axons but the effect on the regeneration of injured axons is limited. Meanwhile, modulating sprouting, a naturally occurring repair mechanism, may be a more attainable therapeutic goal for promoting functional repair after CNS injury in the near term.

Indexed as

AnimalsAxonsCentral Nervous System DiseasesHumansMyelin-Associated GlycoproteinMyelin ProteinsMyelin SheathNerve RegenerationNogo ProteinsOligodendrocyte-Myelin GlycoproteinMyelin-Associated GlycoproteinMyelin ProteinsNogo ProteinsOligodendrocyte-Myelin GlycoproteinRTN4 protein, human

Identifiers

PMID24608164
PMCPMC4122599
OpenAlexW1974663075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.